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Abstract 
Background: The aim was to identify and evaluate existing patient reported outcome 
measures (PROMs) for use in patients with an abdominal aortic aneurysm (AAA) to inform 
the selection for use in surgical practice.  
Methods: Two systematic reviews were conducted: a systematic review to identify valid, 
reliable and acceptable PROMs for patients with AAA and a qualitative evidence synthesis to 
assess the relevance to patients of the identified PROMs items. PROMs studies were 
evaluated for their psychometric properties using established assessment criteria and their 
methodological quality using the COSMIN checklist. Qualitative studies were synthesised 
using framework analysis and identified concepts were then triangulated using a 
triangulation protocol with the item concepts of the identified PROMs.  
Results: Four PROMs from three studies were identified in the first review; the SF-36, the 
Australian Vascular Quality of Life Index, the AneurysmDQoL and AneurysmSRQ.  None of 
the identified PROMs had undergone a rigorous psychometric evaluation within the AAA 
population. Four studies were included in the qualitative synthesis, from which 28 concepts 
important to patients with an AAA were identified.  The AneurysmDQoL and the 
AneurysmSRQ together provided the most comprehensive assessment of these concepts. 
Fear of rupture, control, ability to forget about the condition and size of aneurysm were all 
concepts identified in the qualitative studies but not covered by items on the identified 
PROMs.  
Conclusion: Further research is needed to develop PROMs that are reliable, valid and 
acceptable to patients for use in surgical practice for AAA. 
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Introduction 
Abdominal Aortic Aneurysm (AAA) is a dilation of the abdominal aorta. Recent statistics from 
the UK screening program suggest an incidence of 1.3% for men1. Most AAAs are reported 
to be asymptomatic but rupture is usually fatal2. In 2010 the UK National Health Service 
(NHS) introduced a National Abdominal Aortic Aneurysm Screening Programme (NAAASP) 
for all men aged 65 years as a way of improving mortality rates in this population by 
monitoring and surgical intervention. However, despite an expected increase in elective 
repairs due to the introduction of screening recent evidence from the National Vascular 
Registry3 suggests that the number of repairs is stable or reducing slightly. It is generally 
recommended that AAAs over 5.5cm be considered for surgical repair. Early detection 
combined with advances in surgical techniques such as endovascular repair (EVAR) has 
improved the morbidity and mortality rates4, although there remains debate about the effect 
on long term outcomes. 
Patient reported outcome measures (PROMs) are questionnaires designed to provide a 
means of measuring health or quality of life (QoL) from the patient’s perspective. They 
enable post-surgical outcomes (e.g. social functioning, emotional well-being) wider than the 
traditional measures of outcome such as mortality or morbidity to be recorded5. They can 
capture changes to health status and QoL throughout the process of care and allow 
information to be recorded on the impact of different surgical techniques to help inform 
treatment decisions6. The use of PROMs is becoming more widespread. Since 2009 the 
NHS has made it a requirement to collect PROM data from patients before and after surgery 
in four surgical conditions: hip replacement, knee replacement, varicose veins and groin 
hernia. 
PROMs can be categorised as being generic or condition specific. Both of these may also 
have utility (preference) values estimated for the responses and therefore become 
preference-based measures. Generic PROMs allow for comparisons to be made across 
patient groups and, if preference based, can be used to estimate preference weights for 
calculating quality-adjusted life years (QALYs), allowing for the economic value of 
interventions to be assessed. However generic PROMs do not always appropriately 
measure the specific symptoms and health impact of individual conditions. Condition specific 
PROMs allow greater detail to be collected on a patient disease group and therefore can be 
more useful in a clinical setting. It is generally recommended to use both a generic and a 
condition specific PROM for measuring patient outcomes7. 
There are many PROMs available and it is important to use those that have followed best 
practice in terms of their development and evaluation in the population in which they are 
4 
 
 
being used. The Food and Drug Administration (FDA)8 issued guidance on PROM 
development recommends that the items and domains covered by a PROM are developed 
through qualitative studies and are “appropriate and comprehensive relative to its intended 
measurement concept, population, and use”8.  
The overarching aim of the current study was to synthesise and critically appraise the 
properties of PROMs available for patients with an AAA to aid recommendations for their use 
in surgical practice. These reviews form part of a larger study funded by the NIHR concerned 
with selecting PROMs for use in vascular services. The specific objectives were (i) to 
conduct a systematic review of the literature to identify and appraise the psychometric 
properties of validated PROMs for AAA; (ii) to carry out a qualitative evidence synthesis of 
the qualitative literature to identify health and QoL themes reported by patients; and (iii) to 
triangulate the identified PROM items with the qualitative review themes. 
 
Methods 
Two reviews were conducted; the first was a systematic review of PROMs validated in 
patients with an AAA and the second a qualitative evidence synthesis to identify health and 
quality of life outcomes from patients. 
Review 1: a systematic review of AAA PROMs  
The systematic review was reported in accordance to the Preferred Reporting Items for 
Systematic Reviews and Meta-Analysis (PRISMA) recommendations9. The study protocol is 
available at 
http://www.shef.ac.uk/polopoly_fs/1.550136!/file/Patient_reported_outcome_measures_in_p
atients_with_abdominal_aortic_aneurysms. 
Searches 
Systematic searches were undertaken in eight electronic databases and research registers 
(including Medline and the Cochrane Library) using a two-stage approach. Stage one 
combined terms for known generic and condition-specific PROMs and terms for AAA. These 
results were examined for additional PROM terms used in patients with AAA. These terms 
were added to the preliminary search strategy and combined with a methodological search 
filter for finding studies on measurement properties10. Databases were searched from 
inception up to September 2014 (Stage 1) and to November 2014 (Stage 2).  No language 
or date restrictions were applied.  Searches were supplemented by hand-searching 
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reference lists of relevant reviews and included studies and contact with experts in the ﬁeld.  
Further details of the search strategies are provided in the supplementary appendix 1. 
Study selection 
All titles were examined and any citations that clearly did not meet the inclusion criteria (e.g. 
non-human, unrelated to AAA) were excluded.  All abstracts and full text articles were then 
reviewed by at least two individuals (ME and EP).  Any disagreements in the selection 
process were resolved by discussion, with involvement of a third reviewer when necessary 
(PP).  Eligible studies included published articles in English of any study design that reported 
the psychometric properties of PROMs capturing QoL, health status or functional limitation in 
patients with AAA. Psychometric properties included the validity (the degree to which the 
instrument measures what it is supposed to measure); reliability (the degree to which 
measures are reproducible and consistent over time in patients with a stable condition); 
responsiveness (the degree to which the instrument detects meaningful change over time if 
a change truly exists) and acceptability (the degree to which the instrument is acceptable to 
the patients). Studies reporting only outcomes of treatment satisfaction were excluded. The 
population of interest were any patients with a diagnosis of AAA undergoing screening or 
any treatment, regardless of clinical presentation, diagnostic criterion or underlying cause. 
Studies published in English that reported non-English translations of relevant PROM 
instruments or PROMs elicited from non-English speakers were excluded. This was 
considered as a suitable approach to overcome the uncertainty due to language validation 
and cross-cultural adaptation of PROMs11.  
Data abstraction  
Data relating to study design, patient characteristics, type of PROM, methods and outcomes, 
were extracted by one reviewer into a standardised data extraction form and independently 
checked for accuracy by a second. Any discrepancies were resolved by discussion, with 
involvement of a third reviewer. Where necessary, study authors were contacted for missing 
information or additional data.   
Psychometric evaluation and methodological quality assessment of PROMs 
The psychometric properties and methodological quality of each PROM were appraised by 
two researchers (RD and AK). Disagreements in the ratings were discussed and if needed 
agreed by a third researcher (GJ). PROMs were classified according to whether they were 
generic or condition specific, generic preference based or condition specific preference 
based.  
 
Due to lack of consensus on how to appraise PROMs, study-specific criteria adapted from 
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published recommendations were used to evaluate the psychometric performance of 
identified validated PROMS8,12-16. The developed criteria were also consistent with FDA 
guidance8 and are outlined in Table 1.  
 
Table 1: Appraisal criteria for assessing the psychometric properties of patient 
reported outcome measures 
 
Domain Criteria 
Test re-test 
 
The intra-class correlation/ weighted kappa score should be ≥0.70 for group 
comparisons  and ≥ 0.90 if scores are going to be used for decisions about an 
individual based on their score13.  
  
The mean difference (paired t test or Wilcoxon signed-rank test) between 
time point 1 (T1) and time point 2 (T2) and the 95% CI should also be 
reported. 
Internal 
consistency 
 
A Cronbach’s alpha score of ≥0.70 is considered good and it should not 
exceed ≥0.92 for group comparisons as this is taken to indicate that items in 
the scale could be redundant.  Item total correlations should be ≥0.2015.  
Content validity 
 
This is assessed qualitatively during the development of an instrument. To 
achieve good content validity, there must be evidence that the instrument has 
been developed by consulting patients, experts as well as undertaking a 
literature review.  
 
Patients should be involved in the development stage and item generation. 
The opinion of patient representatives should be sought on the constructed 
scale13,14,15. 
Construct validity A correlation co-efficient of ≥0.60 is taken as strong evidence of construct 
validity. Authors should make specific directional hypotheses and estimate 
the strength of correlation before testing13,15,16.  
Criterion validity 
 
A good argument should be made as to why an instrument is a gold standard 
and correlation with the gold standard should be ≥ 0.7016.  
Responsiveness 
 
There are a number of methods to measure this including t-tests, effect size, 
standardised response means or responsiveness statistics Guyatts’ 
responsiveness index. There should be statistically significant changes in 
score of an expected magnitude33.  
Floor-ceiling effects  A floor or celling effect is considered if 15% of respondents are achieving the 
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lowest or the highest score on the instrument16. 
Acceptability  
 
Acceptability was measured by the completeness of the data supplied. 80% 
or more of the data should be complete14.  
 
 
Review 2: a qualitative evidence synthesis 
 
Qualitative searches 
In accordance with the study protocol (see 
https://www.shef.ac.uk/polopoly_fs/1.552397!/file/DP_16_05.pdf) searches were conducted 
in bibliographic databases (including Medline and CINAHL) in April 2015. The search was 
based on the search strategy created for the related review of patient reported outcome 
measures for AAA. The search strategy combined condition terms, terms for patient reported 
outcomes/patient views and terms for qualitative studies (which augmented a qualitative 
study filter)17. Further details of the search strategies are provided in the supplementary 
appendix 1.  
Qualitative study selection 
Two reviewers (RD, PP) read the titles and abstracts for the inclusion/ exclusion criteria. Full 
text articles were obtained for abstracts that appeared to meet the inclusion criteria for more 
detailed information. All titles were examined and any citations that clearly did not meet the 
inclusion criteria (e.g. non-human, unrelated to AAA) were excluded.  Eligible studies 
included published articles in English of primary qualitative studies (e.g. focus groups and 
interviews) that explored AAA (any patients with a diagnosis of AAA undergoing screening or 
any treatment, regardless of clinical presentation, diagnostic criterion or underlying cause) 
patient’s experiences, health or QoL. Studies that did not report qualitative themes in their 
results were excluded. Due to the paucity of qualitative research studies identified in the 
initial searches a decision was made to include those studies conducted in a non-English 
speaking population on the basis that they would provide insight into the impact of AAA.  
Qualitative data extraction and analysis 
Data were extracted and tabulated on authors, date of publication, country of study, number 
of participants, research aims, method of recruitment, method of data collection, key results 
and analysis. The results and discussion sections of each article including primary and 
secondary text (patient quotes reported in the articles and themes) were coded. The text of 
each article was analysed using framework analysis18 to identify themes from within and 
across the articles. The researcher (RD) familiarised themselves with the themes presented 
in the results and discussion section of each article. They then went through each section 
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coding to identify initial themes. Text from each of the included studies was collated by the 
researcher into themes and charted by study to create a framework matrix. Themes were 
examined for their conceptual similarities and differences. The themes that arose were then 
checked by a second reviewer with extensive experience of qualitative reviewing (AB) and 
differences of conceptualisation were discussed and subsequently adjusted.  
The Critical Appraisal Skills Programme (CASP) qualitative research checklist was used to 
assess the methodological quality of the included studies19. CASP consists of 10 questions 
about the qualitative methodology and are answered either as yes, no or unclear. 
Triangulation of PROM items with qualitative themes 
Items from the identified PROMs were mapped against the themes from the qualitative 
synthesis to explore whether the PROMs items captured the themes important to patients. A 
triangulation approach20,21 was followed whereby the researcher examined the themes from 
both the qualitative review and the PROM items/ domains to evaluate whether the concepts 
were the same (agreement), offered similar concepts (partial agreement), appeared to 
contradict each other (dissonance) or were not present (silence). The FDA8 recommends 
that both a generic and condition specific measure are used when collecting patient 
outcomes.  Therefore it was important to examine the extent to which the items within the 
generic measures corresponded or overlapped with those from the condition-specific 
measures.  
 
Results 
Review 1: systematic review of PROMs 
A total of 1,232 records were identified, of which 65 full-text articles were considered 
potentially eligible for inclusion (including an abstract that reported two measures [the 
Aneurysm Symptom Rating Questionnaire (AneurysmSRQ) and Aneurysm-Dependent 
Quality of Life (AneurysmDQoL)]22 which has subsequently been published23,24. Following 
detailed screening, three studies (reporting on four PROMs) were finally included in this 
review23-26. All the included studies reported the validation of PROMs in patients with AAA.  
The majority of the excluded articles did not clearly report outcomes or present data 
evaluating the measurement properties of PROMs. The Aneurysm Treatment Satisfaction 
Questionnaire (AneurysmTSQ) was excluded as this was a patient satisfaction questionnaire 
not an outcomes assessment23,24. A summary of the process of identifying and selecting the 
relevant literature is presented in Figure 1. 
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Figure 1: PRISMA Flow diagram of study selection 
 
 
 
Study characteristics 
As outlined in Table 2, the three included studies were all prospective studies and 
undertaken in the UK23,24, Australia25  and USA26. Two of the studies reported details of 
designing and piloting the PROMs23-25, whilst one study only reported details of using a 
PROM in patients undergoing AAA surgery.26   
Overall, the studies were of a small to moderate size with the number of patients ranging 
from 9526 to 19123. The proportion of men in the study samples ranged between 82%25,26 to 
90%23 and the mean age ranged from between 72 years26 to 75 years23,25. 
The patients’ clinical diagnosis varied across studies. Both Mangione (1997)26 and Borchard 
(2006)25 included patients with comorbidities; however, in Mangione (1997)26 it was unclear 
what these were. Peach (2006)23 did not report any data related to patient comorbidities. 
Mangione (1997)26 included patients undergoing AAA surgery and those who were 
evaluated pre-operatively and post elective surgery.  Peach (2016)23 included patients who 
had undergone AAA repair (using open or endovascular techniques), or were under pre-
operative surveillance with aneurysm that was below the threshold size for intervention. 
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Bochard (2006)25 included patients who had undergone AAA repair (both open and 
endovascular).   
 
Table 2:  Studies reporting validation of PROMs in patients with AAA 
Author, 
Country 
Study aim(s) Patient 
characteristic 
PROM(s) 
measured, 
Types of 
validation 
assessed 
 
Timing of 
PROM(s) 
assessment 
Authors summary 
of key findings 
Borchard  
200625  
Australia 
(Tasmania) 
To develop a 
vascular 
condition 
specific QoL 
tool appropriate 
for patients 
with AAA and 
applicable to 
patients with 
central and 
peripheral 
occlusive 
vascular 
disease, and to 
compare the 
validity and 
reliability of this 
with the SF-36. 
N=10 (for 
design work) 
 
N=108 
(Questionnaire 
piloted)  
 
Mean age 
(yrs.): 74.7  
 
Male n (%): 
89/108 (82%) 
AUSVIQUOL 
 
Type: condition 
specific QoL 
measure 
 
Validation 
assessed:  
Reliability, 
Content validity, 
Structural validity 
and Hypothesis 
testing 
NR The AUSVIQUOL 
showed better 
reliability than the 
SF-36 in all 
domains and 
statistically better 
in the physical 
function domain 
(P < 0.05). 
 
Conclusion: The 
AUSVIQUOL is 
an appropriate 
tool for the QoL 
assessment of 
patients with AAA 
in the clinical 
setting. 
Mangione  
199726  
USA 
To examine the 
responsiveness 
of SF-36 to 
clinical 
changes in 
three surgical 
groups (total 
hip 
arthroplasty, 
thoracic 
surgery for 
treatment of 
non -small cell 
lung cancer, or 
AAA surgery 
repair) and to 
study how QoL 
changes with 
time  amongst 
these patients  
 
N=95 
 
Mean age 
(yrs.): 72  
 
Male n (%): 
78/95 (82% ) 
SF-36  
 
Type: Generic 
 
Validation 
assessed:  
Internal 
consistency, 
Hypothesis 
testing and 
Responsiveness 
Pre-
operatively 
and at 1, 6 
and 12 
months after 
surgery 
The findings 
indicated that SF-
36 has evidence 
of validity internal 
consistency 
(Cronbach alpha 
between 0.86 to 
0.92 for different 
sub-scales) and is 
responsive to 
expected changes 
in HRQoL after 
elective surgery 
for these 
procedures.   
 
Conclusion:  In 
AAA the 
responsiveness 
was dependent 
on the type of 
surgery and the 
timing of follow-
up, hence,  
multidimensional 
measures are 
needed to fully 
capture changes 
in HRQoL after 
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Author, 
Country 
Study aim(s) Patient 
characteristic 
PROM(s) 
measured, 
Types of 
validation 
assessed 
 
Timing of 
PROM(s) 
assessment 
Authors summary 
of key findings 
surgery  
Peach 
201623,24 
UK 
To develop and 
validate 
PROMs to 
assess 
QoL, 
symptoms and 
treatment 
satisfaction in 
patients with 
AAA 
N=54 (for 
design work) 
N=191 
(Questionnaires 
for quantitative 
psychometric 
analysis) 
 
Mean age 
(yrs.): 75  
 
Male n (%): 
172/191 (90% ) 
1.AneurysmDQoL 
questionnaire  
2. AneurysmSRQ 
 
Type: Disease-
specific 
 
Validation 
assessed:  
Content validity 
Pre-
operative, 6 
weeks and 
12 weeks 
post 
operation  
(but only pre-
operative 
data have 
been 
analysed and 
reported due 
to low 
number at 
follow-up  
A set of newly 
designed and 
validated 
PROMS to 
assess quality of 
life, symptoms 
and treatment 
satisfaction 
amongst 
patients with AAA 
has been 
designed 
Abbreviations: AAA, Abdominal aortic aneurysms; AUSVIQUOL, Australian Vascular Quality of Life Index;  
AneurysmDQoL, Aneurysm Dependent Quality of Life questionnaire; AneurysmSRQ, Aneurysm Symptoms Rating 
Questionnaire; PROM(s), Patient reported outcome measure(s); QoL, Quality of life; SF-36, Medical Outcomes Study 
36-item Short Form 
 
 
 
PROMs data, psychometric evaluation and methodological assessment 
In total, four PROMs were identified where psychometric evaluation had been completed in 
patients with AAA.  One generic PROM was identified; the 36-item Short Form Health 
Survey (SF-36), one generic vascular PROM; the Australian Vascular Quality of Life index 
(AUSVIQUOL) and two condition specific PROMs; the AneurysmDQoL questionnaire and 
linked to this the AneurysmSRQ. The results of the psychometric evaluation and 
methodological quality (rated using the COSMIN checklist) are presented in the 
supplementary appendix 2 and 3. 
Mangione (1997)26 examined the responsiveness of SF-36 to clinical changes in three 
surgical groups (hip arthroplasty, thoracic surgery for treatment of non-small cell lung cancer 
or AAA repair) and studied how QoL changes with time amongst these patients.  The SF-36 
was administered to patients with AAA undergoing elective surgery. Patients completed the 
SF-36 pre-operatively and at 1, 6, and 12 months after surgery.  Patients also completed the 
Specific Activity Scale (SAS). Responses from the SAS, the five validated health transition 
questions, and the global health rating questions were used to evaluate the validity of the 
observed changes in the SF-36. The SF-36 showed evidence of internal consistency and  
construct validity in the patients with AAA26. The correlation coefficient was 0.4 between the 
0 to 100 rating rating scale and the mental health scale of the SF-36 while correlations with 
other domains were lower but statistically significant.  Responsiveness assessed using a 
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relative efficiency statistic ranged from 1.1 to 6.7 in the combined construct showing high 
responsiveness and tests were statistically significant.  Although acceptability could not be 
rated according the agreed criteria one study found that the majority of participants had 
difficulty completing it suggesting low acceptability25.  
The AUSVIQUOL was developed by Borchard et al (2006)25 to specifically measure the QoL 
of patients with vascular disease and of those with AAA in a clinical setting. The items and 
domains of AUSVIQUOL were determined by examination of a prospective database for 
frequency of symptoms and an in-depth interview of a random sample of AAA patients. The 
AUSVIQUOL has three main domains relating to perception of general health; functional, 
mobility and pain; and psycho-social aspects. The AUSVIQUOL was developed with patients 
and has excellent content validity25; however, the content validity was rated good according 
to the established psychometric criteria. The construct validity of the tool was tested by 
comparing it with SF-36 in 60 patients who underwent endovascular AAA repair and 48 
patients who underwent open AAA repair using factor analysis and regression analysis. As 
no correlation coefficients were reported, construct validity could not be rated. To compare 
the reliability of the two tools, 22 patients were reassessed using SF-36 and AUSVIQUOL. 
Given the low sample the test re-test reliability was rated poor.   
The AneurysmDQol and the AneurysmSRQ, were developed and validated by Peach 
201623,24. They used semi-structured interview techniques to explore patients’ experience of 
having AAA in a series of focus groups and in-depth interviews.  The information gathered 
was used to inform design and selection of items for the new tools.  The AneurysmDQoL 
consists of 24-items with 22 domains specific to patients with AAA with a further two 
additional items to assess overall QoL and the impact of AAA on QoL. The AneurysmSRQ is 
a 44-item, aneurysm-specific measure, which assesses a wide range of physical and 
psychological symptoms reported by patients with AAA with two free-text questions. The 
tools were further completed by 191 patients from the NHS Trusts for psychometric 
validation assessment. The initial validation of the tools reported the trend scores of the 
different instruments but did not report psychometric properties of the measures. However, 
the tool shows good content validity according to standardised psychometric appraisal 
criteria23.  
Review 2: qualitative evidence synthesis 
Figure 1 presents a summary of the selection process. 315 citations were identified through 
the database searches, on sifting 85 duplicates were excluded leaving 230 studies. The 230 
titles and abstracts were assessed and 202 citations were subsequently excluded from the 
review. The remaining 28 full text papers were screened against the eligibility criteria and 25 
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papers were excluded leaving a remaining three studies that met the inclusion/ exclusion 
criteria. Through the quantitative review an abstract for the development of a new condition 
specific PROM for AAA was identified22. On contacting the authors they agreed to share the 
methods paper for the PROM development, which was subsequently published23,24. This has 
been included in both reviews; four studies were therefore included in the qualitative 
synthesis. 
The author, research design, study aims, number of participants, diagnosis, mean age, 
gender and main findings of the studies included in the qualitative synthesis are presented in 
Table 3. Three of the four included studies were conducted in Sweden in Swedish, although 
the texts of the articles were published in English27-29. Two of the four studies identified 
carried out semi-structured interviews with patients who had been identified as having an 
AAA through screening and were being treated conservatively27,29, one focussed on patients 
who received surgery for an open repair of the AAA28 and the final presented a mix of 
patients including those being conservatively treated, open repair and endovascular 
repair23,24. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Qualitative studies of patients with an AAA 
 
Author Research 
design 
Study aims Patient 
characteristics 
Diagnosis Main findings 
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Author Research 
design 
Study aims Patient 
characteristics 
Diagnosis Main findings 
Brännström 
(2009)27 
Semi-
structured 
interview 
To describe 
patients’ 
experiences 
5 years after 
being 
informed 
about having 
an AAA in 
the subgroup 
of patients 
with a low 
SF-36 
mental 
health 
scores. 
N=3 
 
Mean 
aged=79.5 
 
Male n 
(%)=100 
 
Participating in 
QoL study 
having had an 
AAA identified 
at screening. 
Patients like 
professional 
care despite 
awareness of 
having an AAA.  
Letterstål 
(2010)28  
Semi-
structured 
interviews 
To elucidate 
patients’ 
lived 
experience 
of the care 
pathway of 
going 
through open 
surgery for 
AAA. 
N=10 
 
Mean aged=73 
 
Male n (%)=60 
Patients 
treated with 
elective open 
surgical repair 
for AAA. 
It was found 
that people 
undergoing 
surgery were 
not fully aware 
of the risks and 
consequences 
of having the 
surgery and 
were 
unprepared for 
the limitations 
of the recovery 
period. 
Pettersson 
(2013)29 
Unstructured 
interviews 
To describe 
patients’ 
experiences 
of living with 
AAA for 
which they 
are receiving 
conservative 
treatment. 
N=10 
 
Mean  
aged= 72.4 
 
Male n (%)=80 
Patients with 
AAA treated 
conservatively. 
5 themes were 
identified: 
sudden 
knowledge of 
an undetected 
condition; 
putting your life 
in someone 
else's hands; 
waiting in limbo 
- feeling secure 
despite 
concerns; life at 
stake; feeling 
obliged not to 
cause worry. 
Peach  
(2016)23,24 
Focus 
groups and 
in-depth 
interviews  
To develop 
three 
questionnair
es to assess 
quality of life 
(QoL), 
symptoms 
and 
treatment 
satisfaction 
in patients 
with AAA. 
N=54(41, 13) 
 
Mean 
aged=71.9 
 
Male n (%)=70 
AAA repair 
within 24 
months (OR or 
EVAR) or 
treated 
conservatively. 
3 PROMs were 
developed 
through patient 
interviews. 
15 
 
 
Author Research 
design 
Study aims Patient 
characteristics 
Diagnosis Main findings 
Abbreviations: AUSVIQUOL, Australian Vascular Quality of Life Index; SF-36, Medical Outcomes Study 36-item 
Short Form; AneurysmDQoL, Aneurysm Dependent Quality of Life scale; AneurysmSRQ, Aneurysm Symptoms 
Rating scale 
 
Quality Assessment 
Against the Critical Appraisal Skills Programme (CASP) checklist19 it was found that all 
studies met ‘yes’ on almost all of the items, showing evidence of being good quality. The 
item on ‘whether the researcher has adequately considered their relationship with 
participants’ was graded as ‘can’t tell’ for two studies27,28 of the three studies as there was 
too little information in the published report. 
Triangulation of the review data 
As presented in Table 4, four overarching themes were identified from the four studies 
included in the qualitative synthesis: health outcomes, functional outcomes, psychological 
outcomes, and social outcomes. A summary of the quotes are provided in supplementary 
appendix 4. 
 
Table 4: PROM items triangulated with the qualitative synthesis themes 
 Qualitative themes AUSVIQUOL SF-36 AneurysmDQoL & 
AneurysmSRQ 
Symptoms 
Feeling no physical symptoms23,24,27,29 . . + 
Pain23,24,27 -/+ -/+ + 
Gastrointestinal upset23,24,28,29 . . + 
Numbness23,24,28 . . + 
Swelling23,24,28 . . + 
Bruising23,24 . . + 
Weakness23,24,28 . . + 
Heaviness23,24 . . + 
Sleep28 -/+ . + 
Lethargy, fatigue23,24,28 . + + 
Weight loss23,24,28 . . + 
Appetite23,24,28 . . + 
Comorbidities27 . . -/+ 
Psychological outcomes 
Concern over bodily 
symptoms23,24,28,29 
. . + 
Concern over changes to the size of 
the aneurysm29 
. . . 
Age related health expectations29 + + + 
Ability to forget about the condition28,29 . . . 
Cognitive function23,24 -/+ . + 
Anxiety27-29 . . + 
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Depression, fatalism, helplessness29 . + + 
Fear of rupture and death23,24,27-29 . . . 
Control29 . . . 
Social outcomes 
Effect on family23,24,29 . + + 
Functional outcomes 
Effect on day to day life23,24,28 + + + 
Sexual Function27 .  + 
Lifting heavy objects23,24,28,29 . + -/+ 
Ability to trave23,24,28,29 . . + 
Financial implications24 . . + 
Key:  
. silence  
– dissonance  
-/+ partial agreement 
+ agreement  
 
N.B. AneurysmDQoL & AneurysmSRQ are reported together as they were developed with the same authors. 
 
 
Symptoms 
This theme included 14 health related concepts from the included studies. These were 
feeling no physical symptoms23,24,27,29; pain23,24,27; gastrointestinal upset23,24,28,29; numbness, 
swelling, bruising, weakness and heaviness23,24,28; sleep28; fatigue23,24,28; weight loss23,24,28; 
appetite23,24,28; changes to the size of the aneurysm and comorbidities27. All items but 
comorbidities and changes to size of the aneurysm were covered by the AneurysmSRQ. The 
SF-36 was rated as having partial agreement with the pain theme and partial agreement with 
a question on fatigue/ lethargy. The AUSVIQUOL also asked about pain and sleep but this 
was combined with another question and therefore was rated as only meeting partial 
agreement. 
Functional outcomes 
Functional items were those that related to everyday activities or physical functioning 
including the effect on day-to-day life23,24,28, sexual function27, lifting heavy objects23,24,28,29, 
ability to travel23,24,28,29 and financial implications24. The AneurysmDQoL or the 
AneurysmSRQ had items that covered all of the identified themes classified under functional 
outcomes. The AUSVIQUOL and the SF-36 both included an item on every day functioning. 
The SF-36 included an item on the ability to lift heavy objects.  
Psychological outcomes 
Concepts included concern over bodily symptoms, age related health perceptions, ability to 
forget about the condition, cognitive function, anxiety, depression, fear of rupture and 
control23,24,27-29. Fear of rupture, control23,24,27-29 and ability to forget about the condition28,29 
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were all themes that were covered in the qualitative studies but silent in the identified 
PROMs items. The AneurysmDQoL or the AneurysmSRQ does not have items on concern 
over aneurysm, ability to forget about the condition, fear of rupture and death or control. The 
SF-36 includes items on depression and concern over bodily symptoms and the 
AUSVIQUOL only on concern over bodily symptoms, and partial agreement with cognitive 
function.  
Social outcomes 
Two studies detailed the effects of AAA on their families and that this worsened their own 
concerns. “Patients expressed that their families were worried and concerned about the 
threat the aneurysm posed to the patient and thereby also to the family 
circumstances”23,24,29. This is in agreement with items on the SF-36 and the AneurysmDQoL.  
 
Discussion 
To our knowledge this study provides the first review of the psychometric properties of 
PROMs for AAA and of the qualitative literature on patients’ experiences of having an AAA. 
The overall aim of the current review was to synthesise and critically appraise PROMs 
psychometrically evaluated in an AAA population to make recommendations for their use in 
surgical practice. The specific objectives were to conduct a systematic review of the 
literature to identify and appraise the psychometric properties of PROMs validated for AAA; 
to carry out a qualitative evidence synthesis to identify the health and QoL themes reported 
by patients; and to triangulate the identified PROM items with the themes from the qualitative 
synthesis. 
The systematic review (review 1) identified four PROMs (from three studies)23-26 that had 
undergone psychometric tests  for use in patients with an AAA. None of the identified 
PROMs had undergone full rigorous psychometric testing within the AAA population. The 
SF-36 showed good evidence of internal consistency, construct validity and responsiveness 
but did show some floor or ceiling effects and one of the studies reported that older patients 
found some of the items irrelevant suggesting low acceptability25. The AUSVIQUOL - a 
generic vascular measure, showed good content validity according to our criteria as it had 
been developed by interviewing patients with an AAA as well as other conditions, although 
the qualitative review paper is not included here as it combines the results of all conditions 
and was thus excluded from the qualitative review 30. The responsiveness and internal 
consistency of the AUSVIQUOL had not been assessed. The AneurysmDQoL and 
AneurysmSRQ are both condition specific measures of health and QoL have compared 
trend scores but a conventional psychometric evaluation has not been performed yet; but 
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were developed from the most comprehensive qualitative study of AAA patient experiences 
including those patients who are receiving conservative, OR, or EVAR treatment. 
Details for the process of tool development were reported by both Borchard (2006)25 and 
Peach (2016)23,24. Both studies had potential issues in respect to item identification and 
retention. The items for the AUSVIQUOL25 were chosen on the basis of the frequency of 
reported symptoms from patients undergoing AAA repair but it was unclear as to how these 
data were captured.  Furthermore, validation of item inclusion and reduction was on the 
basis of semi-structured interviews (n=10) which were centred on the relevance of the items 
already identified rather than checking the breadth and completeness of the identified 
domains. The item selection for the AneurysmDQoL24 was based on focus groups of AAA 
patients and relied on their recall of their treatment. Questions were constructed for the 
identified areas from previously existing questionnaires.  
The qualitative synthesis (review 2) identified only four studies23,24,27-29 reporting on patients’ 
experiences of having an AAA. The themes from these studies when mapped onto the items 
of the identified PROMs found that none of the current PROMs cover all of the concepts 
from the qualitative studies although the AneurysmSRQ and AneurysmDQoL combined 
covered 24 of the 28 identified concepts. Fear of rupture was not captured by any of the 
PROMs despite being recorded as a key theme in all four of the qualitative studies. Similarly, 
difficulty in forgetting about the AAA was reported in two of the qualitative studies but was 
not reflected in the items of the PROMs. It could be fear and ability to forget about the 
condition are associated with distress and so measuring the more general theme of distress 
was thought to cover this concept. Due to the frequency of patients reporting fear around 
AAA, further research is needed to explore this theme and whether it is adequately covered 
by the existing PROMs. 
The main strength of the PROMs review (review 1) was the comprehensive two-step search 
strategy used to identify studies. The review was undertaken by a multi-disciplinary team of 
clinical and methodological experts according to the recommended standards. However 
there were a number of limitations to the review process that should be noted. Firstly, the 
data extraction for the qualitative synthesis (review 2) and triangulation protocol was applied 
by a single researcher (RD). It is known that having two reviewers conducting each stage a 
review reduces the incidence of error 31,32. In this instance the process and emerging themes 
were discussed with an experienced qualitative reviewer (AB). 
Three of the four studies included in the qualitative synthesis (review 2) had been conducted 
in Sweden in Swedish27-29. The PROMs review (review 1) excluded PROMs not developed in 
an English speaking population whereas the qualitative synthesis (review 2) did include 
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studies that had been conducted in another language but published in English. Only one of 
the qualitative studies was conducted in English24 highlighting the paucity of published 
research qualitatively exploring patients’ experiences of the condition.  
Macefield (2014) wrote about the difficulties of comparing concepts PROMs 6. Items within 
the AUSVIQUOL lacked clarity over the conceptual domain they were intending to measure 
making data synthesis with the SF-36 difficult. For example when asking whether pain 
disturbs sleep in the same question they ask whether pain distorts mobility e.g. “do you have 
pain or discomfort in your legs or feet that limits your mobility or disturbs you sleep, ulcers on 
your feet or have you lost a limb?”. It is also unclear whether the questionnaire would relate 
to those who have been identified with an AAA that are not requiring or have not undergone 
surgery.  
Both the qualitative and PROMs studies samples were heterogeneous including patients at 
different stages of treatment. Of the four identified studies only two included patients post 
treatment 23,24,28. There needs to be further exploration of patients post treatment. Peach and 
colleagues provide the most extensive qualitative study including patients at each stage of 
treatment 23,24.  
Despite recent publications on outcomes for patients with AAA as yet there would seem to 
be a paucity of qualitative research in this area with only one UK study23,24 cited. In 
recommending a PROM for use in clinical practice to measure outcomes from surgery it is 
important to include measures that both capture the breadth of the patient experience and 
provide instruments that are reliable, valid and acceptable to patients. Research exploring 
how to integrate PROMs into the patient pathway is needed. If PROMs are to be integrated 
into practice it would be useful to administer the PROMs at different stages of each patient’s 
care over at least two time points.  
 
Conclusion 
Only four PROMs (two generic and two condition specific) and three qualitative studies met 
criteria for inclusion in the review. Of the four PROMs identified by the review the condition 
specific AneurysmSRQ and AneurysmDQoL23,24 appear to relate best to the themes 
identified in the qualitative review. No PROM included items on fear of rupture, death or 
ability to forget about the condition, despite all the qualitative studies identifying these as key 
issues for patients. Further work needs to be done to explore the psychometric properties of 
the current measures and whether additional items are needed. 
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Database: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid 
MEDLINE(R) <1946 to Present> 
Search Strategy: 
-------------------------------------------------------------------------------- 
1. (Aortic aneurysm$ or triple A or true aneurysm$).tw. 
2. Aortic Aneurysm/ 
3. Aortic Aneurysm, Abdominal/ 
4. 1 or 2 or 3 
5. (patient reported outcome$ or patient-reported outcome$).tw. 
6. (prom or proms).tw. 
7. (disease reported outcome$ or disease-reported outcome$).tw. 
8. 5 or 6 or 7 
9. "Quality of Life"/ 
10. "Outcome and Process Assessment (Health Care)"/ 
11. "Outcome Assessment (Health Care)"/ 
12. quality of life.tw. 
13. qol.tw. 
14. outcome measure$.tw. 
15. health outcome$.tw. 
16. or/9-15 
17. (patient adj20 report$).tw. 
18. 16 and 17 
19. 8 or 18 
20. nottingham health profile.tw. 
21. health related quality of life.tw. 
22. health related qol.tw. 
23. health related ql.tw. 
24. hrqol.tw. 
25. hql.tw. 
26. health state utilit$.tw. 
27. hsuv$.tw. 
28. (euroqol or euro qol or eq5d or eq 5d).tw. 
29. (sf6d or sf 6d or sf 6 dimension$ or sf six dimension$ or shortform 6d or shortform six 
dimension$ or short form 6d or short form 6 dimension$ or short form six dimension$).tw. 
30. (sf12 or sf 12 or short form 12 or shortform 12 or sf twelve or sftwelve or shortform 
twelve or short form twelve).tw. 
31. (sf36 or sf 36 or short form 36 or shortform 36 or sf thirtysix or sf thirty six or shortform 
thirtysix or shortform thirty six or short form thirtysix or short form thirty six).tw. 
32. (item adj3 short form).tw. 
33. (item adj3 shortform).tw. 
34. medical outcomes survey.tw. 
35. medical outcomes study.tw. 
36. mos.tw. 
37. psychological general wellbeing index.tw. 
38. psychological general well being index.tw. 
39. pgwb$.tw. 
40. health utilit$.tw. 
41. hui$.tw. 
42. quality of wellbeing.tw. 
43. quality of well being.tw. 
44. qwb$.tw. 
45. rosser.tw. 
46. trade off$.tw. 
47. standard gamble$.tw. 
48. tto$.tw. 
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49. qaly$.tw. 
50. quality adjusted life year$.tw. 
51. quality-adjusted life years/ 
52. hye$.tw. 
53. health$ year$ equivalent$.tw. 
54. disutilit$.tw. 
55. disbenefit$.tw. 
56. "Quality of Life"/ 
57. "Outcome Assessment (Health Care)"/ 
58. quality of life.tw. 
59. 56 or 57 or 58 
60. (preference based or utilit$ or generic preference).tw. 
61. 59 and 60 
62. (preference$ adj2 (elicit$ or patient$ or population$ or measure$ or based or cost$)).tw. 
63. (utilit$ adj2 (elicit$ or patient$ or population$ or measure$ or based or cost$)).tw. 
64. or/20-55 
65. 61 or 62 or 63 or 64 
66. 19 or 65 
67. 4 and 66 
 
AAA Search Strategies: Search Two 
Database: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid 
MEDLINE(R) <1946 to Present> 
Search Strategy: 
-------------------------------------------------------------------------------- 
1. (Aortic aneurysm$ or triple A or true aneurysm$).tw. 
2. Aortic Aneurysm/ 
3. Aortic Aneurysm, Abdominal/ 
4. or/1-3 
5. time trade off.mp. 
6. Watt index.mp. 
7. (Rand-36 or Rand36 or Rand 36).mp. 
8. self-assessed health.mp. 
9. screenQL.mp. 
10. general health questionnaire.mp. 
11. female sexual function index.mp. 
12. Rose questionnaire.mp. 
13. Australian Vascular Quality of Life Index.mp. 
14. AUSVIQUOL.mp. 
15. Nottingham Health Profile.mp. 
16. NHP.mp. 
17. (sf36 or sf 36 or short form 36 or shortform 36 or sf thirtysix or sf thirty six or shortform 
thirtysix or shortform thirty six or short form thirtysix or short form thirty six).mp. [mp=title, 
abstract, original title, name of substance word, subject heading word, keyword heading 
word, protocol supplementary concept word, rare disease supplementary concept word, 
unique identifier] 
18. (sf12 or sf 12 or short form 12 or shortform 12 or sf twelve or sftwelve or shortform 
twelve or short form twelve).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier] 
19. (sf20 or sf 20 or short form 20 or shortform 20 or sf twenty or sftwenty or shortform 
twenty or short form twenty).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier] 
26 
 
 
20. (Hospital Anxiety and Depression Scale).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol supplementary 
concept word, rare disease supplementary concept word, unique identifier] 
21. HADS.mp. 
22. Standard gamble$.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] 
23. rosser.tw. 
24. (euroqol or euro qol or eq5d or eq 5d or eq-5d or eq-5d VAS).mp. [mp=title, abstract, 
original title, name of substance word, subject heading word, keyword heading word, 
protocol supplementary concept word, rare disease supplementary concept word, unique 
identifier] 
25. World Health Organization Quality of Life-BREF.mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique identifier] 
26. WHOQOL-BREF.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] 
27. or/5-26 
28. instrumentation.sh. 
29. methods.sh. 
30. Validation Studies.pt. 
31. Comparative Study.pt. 
32. Psychometrics/ 
33. psychometr*.ti,ab. 
34. clinimetr*.tw. 
35. clinometr*.tw. 
36. "Outcome Assessment (Health Care)"/ 
37. outcome assessment.ti,ab. 
38. outcome measure*.tw. 
39. Observer Variation/ 
40. observer variation.ti,ab. 
41. Health Status Indicators/ 
42. "Reproducibility of Results"/ 
43. reproducib*.ti,ab. 
44. Discriminant Analysis/ 
45. reliab*.ti,ab. 
46. unreliab*.ti,ab. 
47. valid*.ti,ab. 
48. coefficient.ti,ab. 
49. homogeneity.ti,ab. 
50. homogeneous.ti,ab. 
51. "internal consistency".ti,ab. 
52. 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 
43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 
53. cronbach*.ti,ab. 
54. (alpha or alphas).ti,ab. 
55. 53 and 54 
56. item.ti,ab. 
57. (correlation* or selection* or reduction*).ti,ab. 
58. 56 and 57 
59. (agreement or precision or imprecision or "precise values" or "test–retest").ti,ab. 
60. (test and retest).ti,ab. 
61. reliab*.ti,ab. 
62. (test or retest).ti,ab. 
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63. 61 and 62 
64. 55 or 58 or 59 or 60 or 63 
65. (stability or interrater or inter-rater or intrarater or intra-rater or intertester or inter-tester 
or intratester or intra-tester or interobserver or inter-observer or intraobserver or intra-
observer).ti,ab. 
66. (intertechnician or inter-technician or intratechnician or intra-technician or interexaminer 
or inter-examiner or intraexaminer or intra-examiner or interassay or inter-assay or 
intraassay or intra-assay or interindividual or inter-individual or intraindividual or intra-
individual or interparticipant or inter-participant or intraparticipant or intra-participant).ti,ab. 
67. (kappa or "kappa’s" or kappas or repeatab*).ti,ab. 
68. repeatab*.ti,ab. 
69. 65 or 66 or 67 or 68 
70. (replicab* or repeated).ti,ab. 
71. (measure or measures or findings or result or results or test or tests).ti,ab. 
72. 70 and 71 
73. (generaliza* or generalisa* or concordance).ti,ab. 
74. (intraclass and correlation*).ti,ab. 
75. (discriminative or "known group" or factor analysis or factor analyses or dimension* or 
subscale*).ti,ab. 
76. (multitrait and scaling and (analysis or analyses)).ti,ab. 
77. 72 or 73 or 74 or 75 or 76 
78. (item discriminant or interscale correlation* or error or errors or "individual 
variability").ti,ab. 
79. (variability and (analysis or values)).ti,ab. 
80. (uncertainty and (measurement or measuring)).ti,ab. 
81. ("standard error of measurement" or sensitiv* or responsive*).ti,ab. 
82. ((minimal or minimally or clinical or clinically) and (important or significant or detectable) 
and (change or difference)).ti,ab. 
83. (small* and (real or detectable) and (change or difference)).ti,ab. 
84. (meaningful change or "ceiling effect" or "floor effect" or "Item response model" or IRT or 
Rasch or "Differential item functioning" or DIF or "computer adaptive testing" or "item bank" 
or "cross-cultural equivalence").ti,ab. 
85. 78 or 79 or 80 or 81 or 82 or 83 or 84 
86. 52 or 64 or 69 or 77 or 85 
87. 4 and 27 and 86 
 
Databases and Research Registers which were searched:  
 
 MEDLINE and MEDLINE In Process: Ovid.  
 EMBASE: Ovid.  
 Cochrane Library  
o Cochrane Database of Systematic Reviews (CDSR) 
o Database of Abstracts of Reviews of Effects (DARE)  
o Cochrane Central Register of Controlled Trials (CCRCT)  
o Health Technology Assessment Database (HTA)  
o NHS Economic Evaluation Database (NHS EED)  
 CINAHL 
 PROQOLID 
 PsychINFO 
 Science Citation Index Expanded (SCIE): Web of Science  
 
 
AAA Qualitative Literature Review 
Database: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid 
MEDLINE(R) <1946 to Present> 
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Search Strategy: 
-------------------------------------------------------------------------------- 
1     (Aortic aneurysm$ or triple A or true aneurysm$).tw.  
2     Aortic Aneurysm/  
3     Aortic Aneurysm, Abdominal/ 
4     or/1-3 (38292) 
5     *Attitude to Health/  
6     *Self Care/  
7     *Health Knowledge, Attitudes, Practice/  
8     (patient* adj4 (feeling* or emotion* or view* or symptom* or perception* or 
attribute*)).ti,ab.  
9     ("health related quality of life" or "health related qol" or "health related ql" or hrqol or hql 
or "patient reported outcome*" or "patient-reported outcome*" or prom or proms or "disease 
reported outcome*").ti,ab.  
10     ("quality of life" or "qol" or "outcome measure*" or "health outcome*").ti,ab.  
11     *"Quality of Life"/  
12     *"Outcome Assessment (Health Care)"/ or *"Outcome and Process Assessment 
(Health Care)"/  
13     5 or 6 or 7 or 8 or 9 or 10 or 11 or 12  
14     (qualitative* or findings or interview*).mp.  
15     focus groups/ or interviews as topic/  
16     exp qualitative research/  
17     14 or 15 or 16  
18     14 or 15 or 16  
19     4 and 13  
20     17 and 19  
 
*************************** 
 
 
Databases and Research Registers which were searched:  
 
 MEDLINE and MEDLINE In Process: Ovid.  
 EMBASE: Ovid.  
 CINAHL: EBSCO 
 PROQOLID 
 PsychINFO 
 Science Citation Index Expanded (SCIE): Web of Science  
 Social Science Citation Index 
 Proquest dissertation and theses 
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Appendix 2.  Summary of the psychometric properties of generic and condition-specific 
PROMs in patients with an AAA. 
 
PROM Internal 
consistency 
Test-
retest 
Content 
validity 
Construct 
validity 
Responsive
ness 
Floor/ 
ceiling 
Acceptability 
Generic PROMs 
 SF-36  
Mangione 
(1997)26 
+ 0 0 + + -/+ 0 
Borchard 
(2006)25 
0 - 0 -/+ 0 0 ? 
AAA specific PROMs 
AUSVIQUOL  
Borchard 
(2006)25 
0 - + ? 0 0 ? 
Aneurysm-DQoL  
Peach  
(2014)23,24 
0 0 + 0 0 0 0 
Aneurysm-SRQ 
Peach 
(2014)23,24 
0 0 + 0 0 0 0 
Abbreviations: AUSVIQUOL, Australian Vascular Quality of Life Index; SF-36, Medical Outcomes 
Study 36-item Short Form. 
 
N.B. Criterion validity not displayed. 
 
Psychometric and operational criteria: 
 0 Not reported 
 - Evidence not in favour 
 -/+ Weak evidence 
 + Evidence in favour 
 ? Methodological/ reporting issues 
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Appendix 3. Summary of the methodological quality rated using the COSMIN of generic and condition 
specific PROMs in patients with an AAA. 
 
Instrument Internal 
consistency 
Reliability Measure
ment 
error 
Content 
validity 
Structural 
validity 
Hypothesis 
testing 
Responsive
-ness 
Generic PROMs 
SF-36 
Mangione 
(1997)26 
Poor . . . . Good Good 
Borchard 
(2006)25 
. Poor . . Poor Poor . 
Specific PROMs 
AUSVIQUOL 
Borchard 
(2006)25 
. Poor . Excellent Poor Poor . 
Aneurysm-DQoL 
Peach 
(2014)23,24 
. . . Excellent . . . 
Aneurysm-SRQ 
Peach 
(2014)23,24 
. . . Excellent . . . 
Abbreviations: AUSVIQUOL, Australian Vascular Quality of Life Index; SF-36, Medical Outcomes Study 36-
item Short Form. 
 
N.B. Criterion validity not displayed and cross cultural validity not displayed. 
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Appendix 4: A summary of quotes from the qualitative review 
 
 
Theme Quotes 
Symptoms “All patients denied symptoms and did not experience the AAA at all: ‘‘No, I do 
not have any problems at all; I do not feel it.”27 
 
“During focus groups, patients reported a wide range of symptoms that they 
attributed to their aneurysm or its repair. The most common of these was pain, 
with leg pain, lower back pain, abdominal pain and buttock pain being the most 
common (reported in 7, 5, 4 and 4 groups respectively).”24  
 
“40% of interviewees reporting some upset in gastrointestinal function”24  
 
“I was extremely tired, so the first thing I did when I came home was to go to 
bed. The fatigue felt almost physical and it has taken so long to disappear. 
When I forced myself awake I got really unbearable.”28 
 
“I slept very badly, I got sleeping pills. You know, there were more psychological 
issues afterwards (…) things that made one feel a bit anxious. What will happen 
later? Is everything going to heal as planned?”28 
 
Having more difficulties with other diseases or problems in life overshadows the 
awareness about AAA. The patients report that they compare the knowledge of 
having an AAA with other chronic conditions that they really worry about and 
suffer from in their daily lives. These conditions, e.g. pain, were significantly 
worse to live with.”27  
Functional 
outcomes 
“Understanding the seriousness of the situation created distress while waiting for 
surgery and restricted daily life. Restrictions comprised travelling, heavy lifting 
and always making sure to be reachable by telephone”28  
 
“If your aneurysm bursts in the middle of the Atlantic, you’re finished. So I don’t 
travel because of that.”29  
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Psychological 
outcomes 
“I wasn’t worried before, but last autumn, I was scared because my stomach was 
really upset and I had so much gas and stuff so I thought, well, the first thing you 
think of when you’ve got stomach pain is the aneurysm. I rang up and asked if I 
could come for an earlier check-up.”29 
 
“I worked the whole time to distract my thoughts on what could happen before 
the surgery had been performed.”28  
 
“ability to think clearly”24  
 
“if the aneurysm became larger, it was constantly on their minds, and thoughts 
arose about whether it might rupture or require surgery.”29  
 
The texts also revealed a desire to influence, control, or do something to prevent 
the aneurysm from growing or rupturing. However, their questions about how to 
live their lives remained unanswered, leading to a feeling of resignation and 
fatalism.”24 
 
“Understanding the seriousness of the situation created distress while waiting for 
surgery and restricted daily life.”28 
 
“Preoperative anxiety was particularly prevalent, with participants mentioning this 
spontaneously in 8 of the 9 focus groups and describing feelings of having a 
‘ticking time-bomb inside’. Anxiety about surgical intervention was also noted.”24 
 
Social 
outcomes 
. “Patients expressed that their families were worried and concerned about the 
threat the aneurysm posed to the patient and thereby also to the family 
circumstances.”29  
 
 
 
